Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
87 hedge funds and large institutions have $9.59M invested in Vaxart in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 16 closing their positions.
1,291% more call options, than puts
Call options by funds: $153K | Put options by funds: $11K
15% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 20
1.18% less ownership
Funds ownership: 12.16% → 10.98% (-1.2%)
9% less funds holding
Funds holding: 96 → 87 (-9)
31% less capital invested
Capital invested by funds: $13.9M → $9.59M (-$4.35M)
56% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$341K |
| 2 |
CCM
Connective Capital Management
Palo Alto,
California
|
+$268K |
| 3 |
Morgan Stanley
New York
|
+$228K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$142K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$121K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
-$1.36M |
| 2 |
Millennium Management
New York
|
-$970K |
| 3 |
Charles Schwab
San Francisco,
California
|
-$111K |
| 4 |
Two Sigma Investments
New York
|
-$61.4K |
| 5 |
Invesco
Atlanta,
Georgia
|
-$30.3K |
VXRT Hedge Fund Activity: Q4 2023 in Review
87 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q4 2023, worth a combined $9.59M — down 31% from $13.9M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of VXRT and 7 opened new positions — a net loss of 9 holders — while 20 trimmed existing stakes and 23 added.
The largest buyer was Citadel Advisors, adding an estimated $341K. The largest seller was Cantor Fitzgerald, exiting entirely with an estimated $1.36M sold.
- 87 institutional investors held Vaxart (VXRT) as of Q4 2023, down from 96 in Q3 2023.
- Funds reported $9.59M of Vaxart stock for Q4 2023, down 31% quarter-over-quarter.
- 7 funds opened new Vaxart positions in Q4 2023 and 16 closed out, a net change of -9 holders.
- The largest Vaxart buyer in Q4 2023 was Citadel Advisors, an estimated $341K added.
- The largest Vaxart seller in Q4 2023 was Cantor Fitzgerald, an estimated $1.36M sold.
Based on aggregated 13F filings for Q4 2023.